BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24072676)

  • 1. A novel combinatorial nanotechnology-based oral chemopreventive regimen demonstrates significant suppression of pancreatic cancer neoplastic lesions.
    Grandhi BK; Thakkar A; Wang J; Prabhu S
    Cancer Prev Res (Phila); 2013 Oct; 6(10):1015-1025. PubMed ID: 24072676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical systemic toxicity evaluation of chitosan-solid lipid nanoparticle-encapsulated aspirin and curcumin in combination with free sulforaphane in BALB/c mice.
    Thakkar A; Chenreddy S; Thio A; Khamas W; Wang J; Prabhu S
    Int J Nanomedicine; 2016; 11():3265-76. PubMed ID: 27499621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoprevention of pancreatic cancer using solid-lipid nanoparticulate delivery of a novel aspirin, curcumin and sulforaphane drug combination regimen.
    Sutaria D; Grandhi BK; Thakkar A; Wang J; Prabhu S
    Int J Oncol; 2012 Dec; 41(6):2260-8. PubMed ID: 23007664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemopreventive activity of Oltipraz against N-nitrosobis(2-oxopropyl)amine (BOP)-induced ductal pancreatic carcinoma development and effects on survival of Syrian golden hamsters.
    Clapper ML; Wood M; Leahy K; Lang D; Miknyoczki S; Ruggeri BA
    Carcinogenesis; 1995 Sep; 16(9):2159-65. PubMed ID: 7554069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel nano-drug combination therapeutic regimen demonstrates significant efficacy in the transgenic mouse model of pancreatic ductal adenocarcinoma.
    Thakkar A; Desai P; Chenreddy S; Modi J; Thio A; Khamas W; Ann D; Wang J; Prabhu S
    Am J Cancer Res; 2018; 8(10):2005-2019. PubMed ID: 30416852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Big punches come in nanosizes for chemoprevention.
    Sharma D; Sukumar S
    Cancer Prev Res (Phila); 2013 Oct; 6(10):1007-10. PubMed ID: 24072677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of chemopreventive agents in nanoparticles for cancer prevention.
    Yang CS; Wang H; Hu B
    Cancer Prev Res (Phila); 2013 Oct; 6(10):1011-4. PubMed ID: 24072675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular mechanism of action of aspirin, curcumin and sulforaphane combinations in the chemoprevention of pancreatic cancer.
    Thakkar A; Sutaria D; Grandhi BK; Wang J; Prabhu S
    Oncol Rep; 2013 Apr; 29(4):1671-7. PubMed ID: 23404329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemopreventive effects of 4-methylthio-3-butenyl Isothiocyanate (Raphasatin) but not curcumin against pancreatic carcinogenesis in hamsters.
    Okamura T; Umemura T; Inoue T; Tasaki M; Ishii Y; Nakamura Y; Park EY; Sato K; Matsuo T; Okamoto S; Nishikawa A; Ogawa K
    J Agric Food Chem; 2013 Mar; 61(9):2103-8. PubMed ID: 23387327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of ibuprofen loaded solid lipid nanoparticles and its combination regimens for pancreatic cancer chemoprevention.
    Thakkar A; Chenreddy S; Wang J; Prabhu S
    Int J Oncol; 2015 Apr; 46(4):1827-34. PubMed ID: 25652350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide-donating aspirin prevents pancreatic cancer in a hamster tumor model.
    Ouyang N; Williams JL; Tsioulias GJ; Gao J; Iatropoulos MJ; Kopelovich L; Kashfi K; Rigas B
    Cancer Res; 2006 Apr; 66(8):4503-11. PubMed ID: 16618778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic insights into chemopreventive effects of phenethyl isothiocyanate in N-nitrosobis(2-oxopropyl)amine-treated hamsters.
    Nishikawa A; Lee IS; Uneyama C; Furukawa F; Kim HC; Kasahara K; Huh N; Takahashi M
    Jpn J Cancer Res; 1997 Dec; 88(12):1137-42. PubMed ID: 9473730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of benzyl isothiocyanate and sulforaphane but not resveratrol against initiation of pancreatic carcinogenesis in hamsters.
    Kuroiwa Y; Nishikawa A; Kitamura Y; Kanki K; Ishii Y; Umemura T; Hirose M
    Cancer Lett; 2006 Sep; 241(2):275-80. PubMed ID: 16386831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of N-nitrosobis(2-oxopropyl)amine-induced pancreatic carcinogenesis in hamsters by pioglitazone, a ligand of peroxisome proliferator-activated receptor gamma.
    Takeuchi Y; Takahashi M; Sakano K; Mutoh M; Niho N; Yamamoto M; Sato H; Sugimura T; Wakabayashi K
    Carcinogenesis; 2007 Aug; 28(8):1692-6. PubMed ID: 17449904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cyclooxygenase-2 inhibitor, nimesulide, inhibits postinitiation phase of N-nitrosobis(2-oxopropyl)amine-induced pancreatic carcinogenesis in hamsters.
    Furukawa F; Nishikawa A; Lee IS; Kanki K; Umemura T; Okazaki K; Kawamori T; Wakabayashi K; Hirose M
    Int J Cancer; 2003 Apr; 104(3):269-73. PubMed ID: 12569549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticulate delivery of novel drug combination regimens for the chemoprevention of colon cancer.
    Kanthamneni N; Chaudhary A; Wang J; Prabhu S
    Int J Oncol; 2010 Jul; 37(1):177-85. PubMed ID: 20514409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoprevention of colon cancer in a rat carcinogenesis model using a novel nanotechnology-based combined treatment system.
    Chaudhary A; Sutaria D; Huang Y; Wang J; Prabhu S
    Cancer Prev Res (Phila); 2011 Oct; 4(10):1655-64. PubMed ID: 21914855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemopreventive effects of phenethyl isothiocyanate on lung and pancreatic tumorigenesis in N-nitrosobis(2-oxopropyl)amine-treated hamsters.
    Nishikawa A; Furukawa F; Uneyama C; Ikezaki S; Tanakamaru Z; Chung FL; Takahashi M; Hayashi Y
    Carcinogenesis; 1996 Jun; 17(6):1381-4. PubMed ID: 8681460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemopreventive effect of resveratrol and apocynin on pancreatic carcinogenesis via modulation of nuclear phosphorylated GSK3β and ERK1/2.
    Kato A; Naiki-Ito A; Nakazawa T; Hayashi K; Naitoh I; Miyabe K; Shimizu S; Kondo H; Nishi Y; Yoshida M; Umemura S; Hori Y; Mori T; Tsutsumi M; Kuno T; Suzuki S; Kato H; Ohara H; Joh T; Takahashi S
    Oncotarget; 2015 Dec; 6(40):42963-75. PubMed ID: 26556864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of sarcophytol A on pancreatic carcinogenesis after initiation by N-nitrosobis(2-oxypropyl)amine in Syrian hamsters.
    Yokomatsu H; Hiura A; Tsutsumi M; Satake K
    Pancreas; 1996 Aug; 13(2):154-9. PubMed ID: 8829183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.